Argenx
ARGX
#402
Rank
NZ$106.41 B
Marketcap
NZ$1,692
Share price
-1.73%
Change (1 day)
3.46%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report